Because in patients with type 2 diabetes insulin therapy retained the ability to lower blood glucose despite hyperinsulinemia and insulin resistance, many hoped that, despite hyperleptinemia, leptin therapy might be effective in typical obesity and obesity-associated diabetes. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.